Target intelligence / Profile preview

Biocompatibility

01

Overview

Biocompatibility is defined as the ability of a material to perform with an appropriate host response in a specific application. It is not a single molecular target, receptor, or enzyme, but rather a complex property of biomaterials used in medical devices, implants, and drug delivery systems. The assessment of biocompatibility involves evaluating how a material interacts with various biological components, including blood, tissues, and the immune system, to ensure that it does not cause unacceptable harm or adverse reactions such as toxicity or rejection (Williams, 2008). These interactions are dictated by the material's surface chemistry, topography, and mechanical properties. Because biocompatibility is a situational property rather than a biological molecule, it cannot be 'targeted' by drugs in the traditional sense; instead, it is a requirement that therapeutic systems must satisfy to be safely used in humans (ISO 10993-1:2018). Failure to maintain biocompatibility can lead to chronic inflammation, fibrous encapsulation, or systemic toxicity.

Other names
Biological compatibilityMaterial compatibilityTissue compatibility
02

Mechanism of action

Not applicable as biocompatibility is a property of a material's interaction with a biological system rather than a drug target mechanism.

03

Biological functions

Immune response modulationHemocompatibilityTissue integration
04

Disease associations

Implant rejectionChronic inflammationThrombosisForeign body response
05

Safety considerations

ToxicityImmunogenicityThrombogenicityCarcinogenicityMutagenicity
06

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Complement activation products (C3a, C5a)Tumor necrosis factor-alpha (TNF-alpha)

Beyond the preview

Go deeper on Biocompatibility.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biocompatibility.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call